| ASSET | YEAR | % RETURN |
|---|---|---|
Digi Power X (DGXX) | 2018 | -98.94% |
eXp World (AGNT) | 2018 | -97.13% |
Altimmune (ALT) | 2018 | -96.63% |
Ocugen (OCGN) | 2018 | -95.69% |
Nutex Health (NUTX) | 2018 | -94.89% |
Red Cat (RCAT) | 2018 | -92.86% |
HIVE Digital Technologies (HIVE) | 2018 | -92.78% |
Achieve Life Sciences (ACHV) | 2018 | -91.71% |
Ferroglobe (GSM) | 2018 | -90.1% |
Rezolute (RZLT) | 2018 | -89.41% |
Tenax Therapeutics (TENX) | 2018 | -87.9% |
MiMedx (MDXG) | 2018 | -85.82% |
Gevo (GEVO) | 2018 | -83.39% |
X4 Pharmaceuticals (XFOR) | 2018 | -81.82% |
Palisade Bio (PALI) | 2018 | -81.76% |
Neurogene (NGNE) | 2018 | -81.76% |
Alto Ingredients (ALTO) | 2018 | -81.1% |
Adient (ADNT) | 2018 | -80.5% |
XMax (XMAX) | 2018 | -80.09% |
XMax (XWIN) | 2018 | -80.09% |
Elemental Royalty Corporation Common Stock (ELE) | 2018 | -79.83% |
EverQuote Inc Class A (EVER) | 2018 | -79.7% |
Electrovaya (ELVA) | 2018 | -79.59% |
Puma Biotechnology (PBYI) | 2018 | -79.55% |
Hovnanian Enterprises (HOV) | 2018 | -79.46% |
Small-cap stocks are treated as having a market cap between $300M and $2B.